AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Hoth Therapeutics, Inc. Director's Dealing 2019

Feb 15, 2019

34935_dirs_2019-02-15_7c3e27c4-d738-4bbd-9e79-c3d25a7b44a6.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2019-02-14

Reporting Person: Knie Robb (Director, CEO and President)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	808170	Direct